Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomised trial

Lancet

Volumn 360, Issue 9335, 2002, Pages 743-751

  Fox, K A A ^a   Poole Wilson, P A ^b   Henderson, R A ^c   Clayton, T C ^d   Chamberlain, D A ^e   Shaw, T R D ^f   Wheatley, D J ^g   Pocock, S J ^d  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Western General Hospital ^*  (United Kingdom)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; POTASSIUM CHANNEL STIMULATING AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0037036961     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09894-X     Document Type: Article

References (22)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non ST segment elevation myocardial infarction: executive summary and recommendations. Circulation 2000; 102: 1193-209. http://www.acc.org/clinical/guidelines/unstable/unstable.pdf, accessed Aug 20, 2002.
2. GRACE investigators, Fox K.A.A., Goodman S.G., Klein W., et al. Management of acute coronary syndromes: variations in practice and outcome. Findings of the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 23:2002;1177-1189.
3. Hasdai D., Behar S., Wallentin L., et al. A prospective survey of acute coronary syndromes (Euro Heart Survey ACS). Eur Heart J. 23:2002;1190-1201.
4. Invasive compared with non-invasive treatment in unstable coronary-artery disease . FRISC II prospective randomised multicentre study. Lancet. 354:1999;708-715.
5. FRISC II Investigators, Wallentin L., Lagerqvist B., Husted S., Kontny F., Ståhle E., Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 356:2000;9-16.
6. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
7. TIMI IIIB Investigators . Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Circulation. 89:1994;1545-1556.
8. Boden W.E., O’Rourke R.A., Crawford M.H., et al. The Veterans Affairs non-Q-wave infarction strategy: outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 338:1998;1785-1792.
9. The Joint European Society of Cardiology/American College of Cardiology Committee . Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J. 21:2000;1502-1513.
10. Markiewicz W. Management of unstable coronary-artery disease. Lancet. 355:2000;572-573.
11. Flather M., Perez de Avenaza D., Bakhai A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. N Engl J Med. 345:2001;1573.
12. Brener S.J., Ellis S.G., Schneider J., Topol E.J. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J. 23:2002;869-876.
13. Akkerhuis M.K., Alexander J.H., Tardiff B.E., et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation. 105:2002;544-556.
14. Cohen M., Demers C., Gurfinkel E.P., et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 337:1997;447-452.
15. Antman E.M., McCabe C.H., Gurfinkel E.P., et al. Enoxaparin prevents death and cardiac ischaemic events in unstable angina/non-Q-wave myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 100:1999;1593-1601.
16. Antman E.M., Cohen M., Radley D., et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis. Circulation. 100:1999;1602-1608.
17. National Adult Cardiac Surgical Database Report 1999-2000. The United Kingdom Cardiac Surgical Register. http://www.ctsnet.org/doc/853, accessed Aug 23, 2002.
18. US Society of Thoracic Surgeons National Database. http://www.ctsnet.org/section/stsdatabase, accessed Aug 20, 2002.
19. EUROASPIRE II Study Group . Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 22:2001;554-572.
20. McCulloch P.A., O’Neill W.W., Graham M., et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. J Am Coll Cardiol. 32:1998;596-605.
21. Michalis L.K., Stroumbis C.S., Pappas K., et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery: invasive versus conservative strategy (TRUCS study). Eur Heart J. 23:2000;1909-1910.
22. Spacek R., Widimsky P., Straka E., et al. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicentre randomized trial: the VINO study. Eur Heart J. 23:2002;230-238.